Skip to main content
Tyra Biosciences, Inc. logo

Tyra Biosciences, Inc. — Investor Relations & Filings

Ticker · TYRA ISIN · US90240B1061 US Professional, scientific and technical activities
Filings indexed 368 across all filing types
Latest filing 2025-06-17 Director's Dealing
Country US United States of America
Listing US TYRA

About Tyra Biosciences, Inc.

https://tyra.bio/

Tyra Biosciences, Inc. is a clinical-stage biotechnology company focused on developing next-generation precision medicines. The company specializes in therapies targeting fibroblast growth factor receptor (FGFR) biology, aiming to overcome tumor resistance and address key drivers of disease. Utilizing its proprietary SNÅP Discovery Engine, Tyra Biosciences designs innovative molecular structures. Its lead clinical program involves the development of oral dabogratinib for the treatment of skeletal dysplasia and urologic cancers.

Recent filings

Filing Released Lang Actions
Director's Dealing 2025
Director's Dealing
2025-06-17 English
4
Director's Dealing
2025-06-17 English
Regulatory Filings 2025
Regulatory Filings
2025-06-16 English
Regulatory Filings 2025
Regulatory Filings
2025-06-13 English
Regulatory Filings 2025
Regulatory Filings
2025-06-12 English
Director's Dealing 2025
Director's Dealing
2025-06-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.